Patent · US Expired

Methods and compositions of monoclonal antibodies specific for beta-amyloid proteins

US7060270B2 · kind B2 · utility

31Cited by

2References

5Claims

0Family size

Assignee

Diagenics International Corporation · US

Inventors

Yves Claude Nicolau · Newton, US
Ruth Greferath · Kehl, DE

Key dates

Filing date	Nov 4, 2002
Grant date	Jun 13, 2006
Priority date	—
Expiry date	Nov 29, 2023

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides methods and compositions for the detection, diagnosis and treatment of amyloid-associated diseases, in particular, diseases comprising deposition of amyloid assemblies, fibrils, filaments, tangles, or plaques. A preferred composition comprises monoclonal antibodies that specifically bind amyloid proteins, peptides or fragments and change the conformation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.